EDN1 and pulmonary arterial hypertension: It was reported that plasma ET-1 levels were significantly increased in patients with pulmonary hypertension and that increased ET-1 binding to smooth muscle cell receptors resulted in persistent elevation of ROS levels, further aggravating vascular damage [19].